A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplan
Clinical Trial Grant
Awarded By
Stitching European Myeloma Network
Start Date
October 28, 2024
End Date
October 30, 2029
Awarded By
Stitching European Myeloma Network
Start Date
October 28, 2024
End Date
October 30, 2029